SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,528,179 | -50.9% | 83,201 | -40.9% | 0.19% | -52.2% |
| Q1 2023 | $19,397,781 | +3997.9% | 140,737 | +3752.6% | 0.39% | +4266.7% |
| Q4 2022 | $473,356 | -57.8% | 3,653 | -74.6% | 0.01% | -81.6% |
| Q1 2022 | $1,122,000 | -37.7% | 14,358 | -38.0% | 0.05% | -77.5% |
| Q2 2021 | $1,800,000 | +152.8% | 23,155 | +142.5% | 0.22% | +109.6% |
| Q1 2021 | $712,000 | – | 9,550 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |